Position in JNJ
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$90,319,113
-$161,542,348 QoQ
Shares Held
369,494
-69.6% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.37%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 76.23750318002458.ToString("F0")%
Shared 0.ToString("F0")%
None 23.762496819975425.ToString("F0")%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026LOS ANGELES CAPITAL MANAGEMENT LLC holds $1,172,096,642 across 10 Drug Manufacturers - General names. JNJ ranks #4 (7.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
454,512 | $418,046,502 | |
| 2 | ABBV |
AbbVie Inc.
|
1,260,942 | $274,242,275 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
4,257,069 | $258,191,234 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
369,494 | $90,319,113 | |
| 5 | AMGN |
Amgen Inc
|
187,621 | $66,014,448 | |
| 6 | PFE |
Pfizer Inc
|
1,112,386 | $31,235,798 | |
| 7 | MRK |
Merck & Co., Inc.
|
131,751 | $15,848,327 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
73,460 | $10,238,120 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $90,319,113 | 369,494 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $251,861,461 | 1,217,016 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $178,333,247 | 961,780 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $125,201,995 | 819,653 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $238,873,282 | 1,440,384 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $66,424,110 | 459,301 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $142,637,433 | 880,152 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $143,013,759 | 978,474 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $116,171,097 | 734,377 | Shares | Sole | 2024-04-05 | |
| 2023-12-31 | $111,962,987 | 714,323 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $152,256,839 | 977,572 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $164,548,894 | 994,133 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $149,844,700 | 966,740 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $248,214,801 | 1,405,122 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $214,487,596 | 1,312,975 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $265,332,717 | 1,494,748 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $265,079,543 | 1,495,681 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $242,844,642 | 1,419,563 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $197,723,158 | 1,224,292 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $201,927,254 | 1,225,733 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $232,037,876 | 1,411,852 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $259,289,845 | 1,647,540 | Shares | Sole | 2021-03-10 | |
| 2020-09-30 | $249,423,279 | 1,675,331 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $232,918,015 | 1,656,247 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $211,657,457 | 1,614,104 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||